Taking the transcriptional level of basal time as a reference, our data shows that at the 6th month of anti-TB therapy, DS-TB patients present a negative fold change in TNF, TNFR1, TNFR2 molecules (Fig. 6A–C, respectively). Here, TNF is linked to tuberculosis.